GSK to begin final-stage trials of respiratory syncytial virus vaccine
The virus is a cause of pneumonia in toddlers and the elderly
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Category
Research
Dr Reddy’s, RDIF get DCGI nod for Phase II/III clinical trials of COVID-19 vaccine Sputnik V…
This will be a multicentre and randomised controlled study, which will include safety and immunogenicity study
Scientists to investigate arthritis drug as potential therapy for vascular dementia
New funding by the British Heart Foundation awarded to the Universities of Sheffield and Manchester to investigate the link…
US FDA authorises phase 1 trial of ImmunityBio’s COVID-19 vaccine candidate hAd5
Ongoing development proceeding for oral, inhalational and intranasal administration of hAd5
Eli Lilly pauses trial of antibody drug for COVID-19 over safety concern
The company had said earlier this month that it was applying for EUA for the antibody-drug, LY-CoV555, for patients with mild to…
SPARC announces Phase 3 trial results of SDN-037 to treat inflammation and pain of ocular surgery
The primary efficacy measure was the proportion of subjects with an anterior chamber cell (ACC) grade of zero (0) on Day 15 (zero…
J&J COVID-19 vaccine trial paused due to unexplained illness in participant
The participant's illness is being reviewed and evaluated by an independent data and safety monitoring board, as well as the…
COVID-19 clinical trial disruption declines but trials continue to suffer from slow recruitment
Trials impacted by enrolment suspension have been on a downward trajectory, while the number of clinical trials with delayed…
Janssen presents five year data of STELARA in treatment of Crohn’s Disease
Over half of the patients with moderately to severely active CD who were randomised to subcutaneous ustekinumab every eight weeks…
UK to commence anti-TB BCG vaccine trials to test efficacy against COVID-19
Previous studies suggest that the BCG vaccine could reduce susceptibility to a range of infections caused by viruses including…
Bristol Myers Squibb presents data from True North trial of Zeposia (ozanimod) for ulcerative…
Both primary and all key secondary efficacy endpoints showed statistically significant improvements with oral Zeposia versus…
Umifenovir addition gives no significant clinical benefit in COVID-19 treatment: Glenmark study
The FAITH study enrolled a total of 158 hospitalised patients with moderate COVID-19 in India
Vir Biotech research highlights mechanism to enhance monoclonal antibodies for inducing protective…
The research published in Nature focuses on the role of the Fc domain of monoclonal antibodies, regions with the capacity to bind…
IBRANCE (palbociclib) fails trial for early breast cancer treatment
No unexpected safety signals were observed and it did not meet improved invasive disease-free survival in women with HR+, HER2-…
Givinostat from Italfarmaco gets FDA rare pediatric disease designation in duchenne muscular…
Announces completed enrollment in EPIDYS Phase 3 trial
US FDA awards six clinical trials research grants to develop medical products for rare diseases
FDA received 47 clinical trial grant applications that were reviewed and evaluated for scientific and technical merit by more than…
Experts laud DCGI ruling to conduct phase II/III clinical trials of Sputnik-V in India
The Indian regulator has instructed Dr Reddy’s Laboratories carry out the trials of the vaccine with proper monitoring of immune…
Women creators of genetic ‘scissors’ win Nobel Prize in Chemistry
CRISPR/Cas9 is a common tool in biochemistry and molecular biology labs - used in plant treatments and to develop novel treatments…
NVIDIA partners with GSK’s AI-powered lab for discovery of medicines and vaccines
NVIDIA will contribute its deep expertise in GPU optimisation and high-performance computational pipeline development, including…
Moderna publishes interim results from older adults in phase 1 study of its COVID-19 vaccine
At the 25 µg and 100 µg dose levels, mRNA-1273 was generally well-tolerated in all age cohorts, neutralizing antibody titers and T…